Keen Eye

France Founded: 2013 • Age: 13 yrs
Manufacturer of drug development services for image analysis
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Keen Eye

Keen Eye is a company based in France founded in 2013. Keen Eye operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

  • Headquarter France
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $610.03 K (USD), Grant

    Jan 01, 2020

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Keen Eye

Investors in Keen Eye

Keen Eye has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Keen Eye

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Keen Eye

Investments
Premium access

Investment portfolio details for Keen Eye

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Keen Eye

Premium access

Detailed financials for Keen Eye

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Keen Eye Comparisons

Keen Eye Primary company
Description
Manufacturer of drug development services for image analysis
Location
France
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Keen Eye

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Keen Eye

Keen Eye operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
Locked Locked Locked
AI and cloud-powered software for stroke care coordination is developed.
Locked Locked Locked
AI-powered single cell classification and isolation technology for clinical research
Locked Locked Locked
Digital pathology software is developed for clinical and veterinary productivity.
Locked Locked Locked
AI-based pathology diagnostic software is provided for medical analysis.
Locked Locked Locked
AI-based tools for pathological image analysis are provided to labs.
Premium access

Detailed competitors of Keen Eye

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Keen Eye

Premium access

Complete news archive for Keen Eye

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keen Eye

Keen Eye was founded in 2013 and raised its 1st funding round 7 years after it was founded.

Keen Eye is headquartered in France.

Keen Eye was founded in 2013 and is based in France. Image analysis services are manufactured for the pharmaceutical sector, supporting drug development processes. Operations involve the creation of tools and solutions for analyzing medical images to aid research and testing. The company focuses on biotechnology applications, with activities centered in Europe to serve international clients in the health sciences field.

Keen Eye's top competitors include Aignostics, Deciphex and Pictor Labs.

Keen Eye has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available